Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 8/2015

01-08-2015 | Original Paper

STI/HIV Sexual Risk Behavior and Prevalent STI Among Incarcerated African American Men in Committed Partnerships: The Significance of Poverty, Mood Disorders, and Substance Use

Authors: M. R. Khan, C. E. Golin, S. R. Friedman, J. D. Scheidell, A. A. Adimora, S. Judon-Monk, M. M. Hobbs, G. Dockery, S. Griffin, K. K. Oza, D. Myers, H. Hu, K. P. Medina, D. A. Wohl

Published in: AIDS and Behavior | Issue 8/2015

Login to get access

Abstract

African Americans face disproportionate sexually transmitted infection including HIV (STI/HIV), with those passing through a correctional facility at heightened risk. There is a need to identify modifiable STI/HIV risk factors among incarcerated African Americans. Project DISRUPT is a cohort study of incarcerated African American men recruited from September 2011 through January 2014 from prisons in North Carolina who were in committed partnerships with women at prison entry (N = 207). During the baseline (in-prison) study visit, participants responded to a risk behavior survey and provided a urine specimen, which was tested for STIs. Substantial proportions reported multiple partnerships (42 %), concurrent partnerships (33 %), and buying sex (11 %) in the 6 months before incarceration, and 9 % tested positive for an STI at baseline (chlamydia: 5.3 %, gonorrhea: 0.5 %, trichomoniasis: 4.9 %). Poverty and depression appeared to be strongly associated with sexual risk behaviors. Substance use was linked to prevalent STI, with binge drinking the strongest independent risk factor (adjusted odds ratio: 3.79, 95 % CI 1.19–12.04). There is a continued need for improved prison-based STI testing, treatment, and prevention education as well as mental health and substance use diagnosis.
Literature
1.
2.
3.
4.
U.S. Department of Justice. Bureau of Justice Statistics. Prisoners in 2013. Washington, DC: U.S. Department of Justice; 2014.
5.
Mauer M, King RS. A 25-year quagmire: the war on drugs and its impact on American Society. The Sentencing Project, September Report; 2007.
6.
Adimora AA, Schoenbach V. Social context, sexual networks, and racial disparities in rates of sexually transmitted infections. J Infect Dis. 2005;191:S115–22.PubMedCrossRef
7.
Khan MR, Epperson M, Comfort M. A novel conceptual model that describes the influence of arrest and incarceration on STI/HIV transmission. In: 140th American Public Health Association annual meeting, San Francisco; 2012.
8.
Adimora AA, Schoenbach VJ, Doherty IA. HIV and African Americans in the southern United States: sexual networks and social context. Sex Transm Dis. 2006;33(7):S39–45.PubMedCrossRef
9.
Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS ONE. 2009;4(11):e7558.PubMedCentralPubMedCrossRef
10.
Kouyoumdjian FG, Leto D, John S, Henein H, Bondy S. A systematic review and meta-analysis of the prevalence of chlamydia, gonorrhoea and syphilis in incarcerated persons. Int J STD AIDS. 2012;23(4):248–54.PubMedCrossRef
11.
Khan MR, Miller WC, Schoenbach VJ, Weir SS, Kaufman JS, Wohl DA, et al. Timing and duration of incarceration and high-risk sexual partnerships among African Americans in North Carolina. Ann Epidemiol. 2008;18:403–10.PubMedCentralPubMedCrossRef
12.
Khan MR, Wohl DA, Weir SS, Adimora AA, Moseley C, Norcott K, et al. Incarceration and risky sexual partnerships in a southern US city. J Urban Health. 2008;85(1):100–13.PubMedCentralPubMedCrossRef
13.
Rogers SM, Khan MR, Tan S, Turner CF, Miller WC, Erbelding E. Incarceration, high-risk sexual partnerships and sexually transmitted infections in an urban population. Sex Transmitted Infect. 2012;88(1):63–8.CrossRef
14.
Epperson MW, El-Bassel N, Chang M, Gilbert L. Examining the temporal relationship between criminal justice involvement and sexual risk behaviors among drug-involved men. J Urban Health. 2010;87(2):324–36.PubMedCentralPubMedCrossRef
15.
Whetten K, Reif S. Overview: HIV/AIDS in the deep south region of the United States. AIDS Care. 2006;18(Suppl 1):S1–5.PubMedCrossRef
16.
17.
Centers for Disease Control and Prevention. Tracking the hidden epidemics: trends in STDS in the United States. Atlanta: CDC; 2000.
18.
Khan MR, Behrend L, Adimora AA, Weir SS, Tisdale C, Wohl DA. Dissolution of primary intimate relationships during incarceration and associations with post-release STI/HIV risk behavior in a Southeastern city. Sex Transm Dis. 2011;38(1):43–7.PubMedCentralPubMedCrossRef
19.
Khan MR, Behrend L, Adimora AA, Weir SS, White BL, Wohl DA. Dissolution of primary intimate relationships during incarceration and implications for post-release HIV transmission. J Urban Health. 2011;88(2):365–75.PubMedCentralPubMedCrossRef
20.
Bolton J, Cox B, Clara I, Sareen J. Use of alcohol and drugs to self-medicate anxiety disorders in a nationally representative sample. J Nerv Ment Dis. 2006;194(11):818–25.PubMedCrossRef
21.
Rao U, Daley SE, Hammen C. Relationship between depression and substance use disorders in adolescent women during the transition to adulthood. J Am Acad Child Adolesc Psychiatry. 2000;39(2):215–22.PubMedCrossRef
22.
Mandell W, Kim J, Latkin C, Suh T. Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. Am J Drug Alcohol Abuse. 1999;25(1):117–27.PubMedCrossRef
23.
Hawkins WE, Latkin C, Hawkins MJ, Chowdury D. Depressive symptoms and HIV-risk behavior in inner-city users of drug injections. Psychol Rep. 1998;82(1):137–8.PubMedCrossRef
24.
Mueser KT, Drake RE, Wallach MA. Dual diagnosis: a review of etiological theories. Addict Behav. 1998;23(6):717–34.PubMedCrossRef
25.
Brooner RK, King VL, Kidorf M, Schmidt CW Jr, Bigelow GE. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54(1):71–80.PubMedCrossRef
26.
Castillo Mezzich A, Tarter RE, Giancola PR, Lu S, Kirisci L, Parks S. Substance use and risky sexual behavior in female adolescents. Drug Alcohol Depend. 1997;44(2–3):157–66.PubMedCrossRef
27.
Dinwiddie SH. Characteristics of injection drug users derived from a large family study of alcoholism. Compr Psychiatry. 1997;38(4):218–29.PubMedCrossRef
28.
Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4(5):231–44.PubMedCrossRef
29.
Kalichman SC, Kelly JA, Johnson JR, Bulto M. Factors associated with risk for HIV infection among chronic mentally ill adults. Am J Psychiatry. 1994;151(2):221–7.PubMedCrossRef
30.
Hasin DS, Glick H. Depressive symptoms and DSM-III-R alcohol dependence: general population results. Addiction. 1993;88(10):1431–6.PubMedCrossRef
31.
Latkin CA, Mandell W. Depression as an antecedent of frequency of intravenous drug use in an urban, nontreatment sample. Int J Addict. 1993;28(14):1601–12.PubMed
32.
Stephens RS, Roffman RA, Simpson EE. Adult marijuana users seeking treatment. J Consult Clin Psychol. 1993;61(6):1100–4.PubMedCrossRef
33.
Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry. 1991;48(1):43–51.PubMedCrossRef
34.
Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA. 1990;264(19):2511–8.PubMedCrossRef
35.
Ross HE, Glaser FB, Germanson T. The prevalence of psychiatric disorders in patients with alcohol and other drug problems. Arch Gen Psychiatry. 1988;45(11):1023–31.PubMedCrossRef
36.
Rounsaville BJ, Weissman MM, Crits-Christoph K, Wilber C, Kleber H. Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome. Arch Gen Psychiatry. 1982;39(2):151–6.PubMedCrossRef
37.
Leigh BC, Stall R. Substance use and risky sexual-behavior for exposure to Hiv—issues in methodology, interpretation, and prevention. Am Psychol. 1993;48(10):1035–45.PubMedCentralPubMedCrossRef
38.
Baliunas D, Rehm J, Irving H, Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health. 2010;55(3):159–66.PubMedCrossRef
39.
Cook RL, Clark DB. Is there an association between alcohol consumption and sexually transmitted diseases? A systematic review. Sex Transm Dis. 2005;32(3):156–64.PubMedCrossRef
40.
Latkin CA, Williams CT, Wang J, Curry AD. Neighborhood social disorder as a determinant of drug injection behaviors: a structural equation modeling approach. Health Psychol. 2005;24(1):96–100.PubMedCrossRef
41.
Margolis AD, MacGowan RJ, Grinstead O, Sosman J, Kashif I, Flanigan TP. Unprotected sex with multiple partners: implications for HIV prevention among young men with a history of incarceration. Sex Transm Dis. 2006;33(3):175–80.PubMedCrossRef
42.
Sosman J, Macgowan R, Margolis A, Gaydos CA, Eldridge G, Moss S, et al. Sexually transmitted infections and hepatitis in men with a history of incarceration. Sex Transm Dis. 2011;38(7):634–9.PubMedCrossRef
43.
McNiel DE, Binder RL, Robinson JC. Incarceration associated with homelessness, mental disorder, and co-occurring substance abuse. Psychiat Serv. 2005;56(7):840–6.CrossRef
44.
Meade CS, Sikkema KJ. HIV risk behavior among adults with severe mental illness: a systematic review. Clin Psychol Rev. 2005;25(4):433–57.PubMedCrossRef
45.
Khan MR, Kaufman JS, Pence BW, Gaynes BN, Adimora AA, Weir SS, et al. Depression, sexually transmitted infection, and sexual risk behavior among young adults in the United States. Arch Pediatr Adolesc Med. 2009;163(7):644–52.PubMedCentralPubMedCrossRef
46.
Ramrakha S, Caspi A, Dickson N, Moffitt TF, Paul C. Psychiatric disorders and risky sexual behaviour in young adulthood: cross sectional study in birth cohort. Brit Med J. 2000;321(7256):263–6.PubMedCentralPubMedCrossRef
47.
Reyes JC, Robles RR, Colon HM, Marrero CA, Matos TD, Calderon JM, et al. Severe anxiety symptomatology and HIV risk behavior among Hispanic injection drug users in Puerto Rico. AIDS Behav. 2007;11(1):145–50.PubMedCrossRef
48.
McKirnan DJ, Ostrow DG, Hope B. Sex, drugs and escape: a psychological model of HIV-risk sexual behaviours. AIDS Care. 1996;8(6):655–69.PubMedCrossRef
49.
Lejoyeux M, Arbaretaz M, McLoughlin M, Ades J. Impulse control disorders and depression. J Nerv Ment Dis. 2002;190(5):310–4.PubMedCrossRef
50.
Hanson KL, Luciana M, Sullwold K. Reward-related decision-making deficits and elevated impulsivity among MDMA and other drug users. Drug Alcohol Depend. 2008;96:99–110.PubMedCentralPubMedCrossRef
51.
Rao U. Links between depression and substance abuse in adolescents: neurobiological mechanisms. Am J Prev Med. 2006;31(6 Suppl 1):S161–74.PubMedCrossRef
52.
Aseltine RJ, Gore S, Colten M. Depression and the social development context of adolescence. J Pers Soc Psychol. 1994;67:252–63.PubMedCrossRef
53.
Belenko S, Peugh J. Estimating drug treatment needs among state prison inmates. Drug Alcohol Depend. 2005;77(3):269–81.PubMedCrossRef
54.
MacGowan RJ, Margolis A, Gaiter J, Morrow K, Zack B, Askew J, et al. Predictors of risky sex of young men after release from prison. Int J STD AIDS. 2003;14(8):519–23.PubMedCrossRef
55.
Beckwith CG, Zaller ND, Fu JJ, Montague BT, Rich JD. Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. J Acquir Immune Defic Syndr. 2010;55:S49–55.PubMedCentralPubMedCrossRef
56.
Satterwhite CL, Torrone E, Meites E, Dunne EF, Mahajan R, Ocfemia MC, et al. Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008. Sex Transm Dis. 2013;40(3):187–93.PubMedCrossRef
57.
Westrom L, Eschenbach D. Pelvic inflammatory disease. In: Holmes KK, Sparling PF, Mårdh P, editors. Sexually Transmitted Diseases. 3rd ed. New York: McGraw-Hill; 1999. p. 783–809.
58.
Cohen MS. HIV and sexually transmitted diseases: lethal synergy. Top HIV Med. 2004;12(4):104–7.PubMed
59.
Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999;75(1):3–17.PubMedCentralPubMedCrossRef
60.
Radloff L. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.CrossRef
61.
Perreira KM, Deeb-Sossa N, Harris KM, Bollen K. What are we measuring? An evaluation of the CES-D across race/ethnicity and immigrant generation. Soc Forces. 2005;83(4):1567–601.CrossRef
62.
Lincoln KD, Taylor RJ, Watkins DC, Chatters LM. Correlates of Psychological distress and major depressive disorder among African American men. Res Soc Work Pract. 2011;21(3):278–88.PubMedCentralPubMedCrossRef
63.
Spielberger CD, Gorsuch RL, Lushene RE. Manual for the state-trait anxiety inventory. Palo Alto: Consulting Psychologists Press; 1970.
64.
65.
Gibbs TA, Okuda M, Oquendo MA, Lawson WB, Wang S, Thomas YF, Blanco C. Mental health of African Americans and Caribbean Blacks in the United States: results from the National Epidemiological Survey on alcohol and related conditions. Am J Public Health. 2013;103(2):330–8.PubMedCentralPubMedCrossRef
66.
Taylor RJ, Chae DH, Chatters LM, Lincoln KD, Brown E. DSM-IV twelve month and lifetime major depressive disorder and romantic relationships among African Americans. J Affect Disord. 2012;142(1–3):339–42.PubMedCentralPubMedCrossRef
67.
Draine JWN. Social capital and reentry to the community from prison. New Brunswick: Rutgers University; 2009.
68.
Pope LG, Smith TE, Wisdom JP, Easter A, Pollock M. Transitioning between systems of care: missed opportunities for engaging adults with serious mental illness and criminal justice involvement. Behav Sci Law. 2013;31:444–56.PubMedCrossRef
69.
Rich JD, Wohl DA, Beckwith CG, Spaulding AC, Lepp NE, Baillargeon J, Gardner A, Avery A, Altice FL, Springer S. HIV-related research in correctional populations: now is the time. Curr HIV/AIDS Rep. 2011;8(4):288–96.PubMedCentralPubMedCrossRef
70.
Western B, Muller C. Mass incarceration, macrosociology, and the poor. Ann Am Acad Polit Sci. 2013;647(1):166–89.CrossRef
71.
Adimora AA, Schoenbach VJ, Floris-Moore MA. Ending the epidemic of heterosexual HIV transmission among African Americans. Am J Prev Med. 2009;37(5):468–71.PubMedCentralPubMedCrossRef
72.
Krueger L, Wood RW, Diehr PH, Maxwell CL. Poverty and HIV seropositivity: the poor are more likely to be infected. Aids. 1990;4(8):811–4.PubMedCrossRef
73.
Mair C, Diez Roux AV, Osypuk TL, Rapp SR, Seeman T, Watson KE. Is neighborhood racial/ethnic composition associated with depressive symptoms. The multi-ethnic study of atherosclerosis. Soc Sci Med. 2010;71:541e50.CrossRef
74.
Hudson DL, Neighbors HW, Geronimus AT, Jackson JS. The relationship between socioeconomic position and depression among a US nationally representative sample of African Americans. Soc Psychiatry Psychiatr Epidemiol. 2012;47:373–81.PubMedCentralPubMedCrossRef
75.
Buka SL. Disparities in health status and substance use: ethnicity and socioeconomic factors. Public Health Reports. 2002;117:S118.PubMedCentralPubMed
76.
77.
Fabelo T. The impact of prison education on community reintegration of inmates: The Texas case. J Correct Educ. 2002;52(3):106–10.
78.
Freudenberg N, Ramaswamy M, Daniels J, Crum M, Ompad DC, Vlahov D. Reducing drug use, human immunodeficiency virus risk, and recidivism among young men leaving jail: evaluation of the REAL MEN re-entry program. J Adolesc Health. 2010;47(5):448–55.PubMedCentralPubMedCrossRef
79.
Rich JD, DiClemente R, Levy J, Lyda K, Ruiz MS, Rosen DL, Dumont D. Correctional facilities as partners in reducing HIV disparities. J Acquir Immune Defic Syndr. 2013;63:S49–53.PubMedCentralPubMedCrossRef
Metadata
Title
STI/HIV Sexual Risk Behavior and Prevalent STI Among Incarcerated African American Men in Committed Partnerships: The Significance of Poverty, Mood Disorders, and Substance Use
Authors
M. R. Khan
C. E. Golin
S. R. Friedman
J. D. Scheidell
A. A. Adimora
S. Judon-Monk
M. M. Hobbs
G. Dockery
S. Griffin
K. K. Oza
D. Myers
H. Hu
K. P. Medina
D. A. Wohl
Publication date
01-08-2015
Publisher
Springer US
Published in
AIDS and Behavior / Issue 8/2015
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-015-1062-6

Other articles of this Issue 8/2015

AIDS and Behavior 8/2015 Go to the issue

Original Paper

Health Outcomes of HIV-Infected People with Mental Illness

Original Paper

Looking Beyond Health-Related Quality of Life: Predictors of Subjective Well-Being among People Living with HIV in the Netherlands

Original Paper

Childhood Sexual Abuse and Syringe Sharing Among People Who Inject Drugs

Original Paper

Family Functioning and Child Behavioral Problems in Households Affected by HIV and AIDS in Kenya

Original Paper

Physical Activity is Associated with Better Neurocognitive and Everyday Functioning Among Older Adults with HIV Disease

Substantive Review

Does Food Insecurity Undermine Adherence to Antiretroviral Therapy? A Systematic Review
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits